LXFR Stock Analysis: Luxfer Holdings | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 466m USD | 12M Return: 33.2% | GB00BNK03D49 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.03M
EPS Trend: 75.7%
Qual. Beats: 0
Rev. Trend: -69.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Luxfer Holdings PLC (NYSE: LXFR) is a U.S.-based industrial company that develops and manufactures high-performance materials, components, and high-pressure gas containment devices through two business segments: Gas Cylinders and Elektron. The Gas Cylinders segment produces engineered containment solutions using aluminum alloys and carbon composite technologies for applications spanning medical gas, alternative fuel transportation, aerospace, defense, and space markets. The Elektron segment manufactures specialty materials based on magnesium and zirconium, serving defense (countermeasure flares, infrared decoys), industrial catalysis, advanced ceramics, pharmaceuticals, and fuel cell components. Founded in 1898 and headquartered in Riverside, California, the company has manufactured industrial materials for over 125 years and operates globally across the U.S., U.K., Japan, Canada, Germany, and the broader Asia Pacific region.
Sector context: Luxfer operates in the Industrials sector, specifically within Industrial Machinery & Components, a classification that reflects its focus on engineered specialty materials rather than commodity production. Its product portfolio is heavily weighted toward defense and aerospace end markets, while exposure to alternative fuel containment (hydrogen and CNG for transportation) aligns the business with energy transition demand for lightweight, high-pressure storage solutions.
- Hydrogen and CNG cylinder demand accelerates
- Aerospace defense orders boost Gas Cylinders segment revenue
- Magnesium powder sales lift Elektron segment margins
| Net Income: 8.00m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -4.64 > 1.0 |
| NWC/Revenue: 29.24% < 20% (prev 17.98%; Δ 11.26% < -1%) |
| CFO/TA 0.07 > 3% & CFO 25.8m > Net Income 8.00m |
| Net Debt (57.9m) to EBITDA (34.4m): 1.68 < 3 |
| Current Ratio: 2.33 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.2m) vs 12m ago 0.45% < -2% |
| Gross Margin: 24.83% > 18% (prev 22.46%; Δ 2.37% > 0.5%) |
| Asset Turnover: 92.16% > 50% (prev 101.2%; Δ -8.99% > 0%) |
| Interest Coverage Ratio: 7.32 > 6 (EBIT TTM 22.7m / Interest Expense TTM 3.10m) |
| A: 0.27 (Total Current Assets 185.8m - Total Current Liabilities 79.6m) / Total Assets 389.0m |
| B: 0.27 (Retained Earnings 104.0m / Total Assets 389.0m) |
| C: 0.06 (EBIT TTM 22.7m / Avg Total Assets 394.1m) |
| D: 1.34 (Book Value of Equity 222.7m / Total Liabilities 166.3m) |
| Altman-Z'' = 4.46 = AA |
| DSRI: 1.26 (Receivables 70.0m/61.6m, Revenue 363.2m/403.8m) |
| GMI: 0.90 (GM 22.46% / 24.83%) |
| AQI: 0.99 (AQ_t 0.35 / AQ_t-1 0.35) |
| SGI: 0.90 (Revenue 363.2m / 403.8m) |
| TATA: -0.05 (NI 8.00m - CFO 25.8m) / TA 389.0m) |
| Beneish M = -2.98 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 17.23 with a total of 334,555 shares traded. Over the past week, the price has changed by -0.06%, over one month by -0.40%, over three months by +2.49% and over the past year by +33.19%.
Current recommended Stop Loss: 17.10 (which is 0.8% or 2.2 ATR below the current price).
Luxfer Holdings has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy LXFR.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18.8 | 8.8% |
P/E Trailing = 35.2449
P/E Forward = 11.9048
P/S = 1.2917
P/B = 2.0933
P/EG = 1.7015
Revenue TTM = 363.2m USD
EBIT TTM = 22.7m USD
EBITDA TTM = 34.4m USD
Long Term Debt = 58.3m USD (from longTermDebt, last quarter)
Short Term Debt = 25.0m USD (from shortTermDebt, last fiscal year)
Debt = 69.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.1m
Net Debt = 57.9m USD (calculated: Debt 69.4m - CCE 11.5m)
Enterprise Value = 524.1m USD (466.2m + Debt 69.4m - CCE 11.5m)
Interest Coverage Ratio = 7.32 (Ebit TTM 22.7m / Interest Expense TTM 3.10m)
EV/FCF = 31.84x (Enterprise Value 524.1m / FCF TTM 16.5m)
FCF Yield = 3.14% (FCF TTM 16.5m / Enterprise Value 524.1m)
FCF Margin = 4.53% (FCF TTM 16.5m / Revenue TTM 363.2m)
Net Margin = 2.20% (Net Income TTM 8.00m / Revenue TTM 363.2m)
Gross Margin = 24.83% ((Revenue TTM 363.2m - Cost of Revenue TTM 273.0m) / Revenue TTM)
Gross Margin QoQ = 25.60% (prev 26.10%)
Tobins Q-Ratio = 1.35 (Enterprise Value 524.1m / Total Assets 389.0m)
Interest Expense / Debt = 4.47% (Interest Expense 3.10m / Debt 69.4m)
Taxrate = 42.86% (8.40m / 19.6m)
NOPAT = 13.0m (EBIT 22.7m * (1 - 42.86%))
Current Ratio = 2.33 (Total Current Assets 185.8m / Total Current Liabilities 79.6m)
Debt / Equity = 0.31 (Debt 69.4m / totalStockholderEquity, last quarter 222.7m)
Debt / EBITDA = 1.68 (Net Debt 57.9m / EBITDA 34.4m)
Debt / FCF = 3.52 (Net Debt 57.9m / FCF TTM 16.5m)
Total Stockholder Equity = 226.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.03% (Net Income 8.00m / Total Assets 389.0m)
RoE = 3.54% (Net Income TTM 8.00m / Total Stockholder Equity 226.1m)
RoCE = 7.98% (EBIT 22.7m / Capital Employed (Equity 226.1m + L.T.Debt 58.3m))
RoIC = 4.02% (NOPAT 13.0m / Invested Capital 322.9m)
WACC = 8.93% (E(466.2m)/V(535.6m) * Re(9.88%) + D(69.4m)/V(535.6m) * Rd(4.47%) * (1-Tc(0.43)))
Discount Rate = 9.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 24.71 | Cagr: 0.58%
[DCF] Terminal Value 70.95% ; FCFF base≈24.0m ; Y1≈21.1m ; Y5≈17.0m
[DCF] Fair Price = 7.10 (EV 249.5m - Net Debt 57.9m = Equity 191.6m / Shares 27.0m; r=8.93% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 75.71 | EPS CAGR: 27.34% | SUE: 0.23 | # QB: 0
Revenue Correlation: -69.71 | Revenue CAGR: -3.19% | SUE: 0.81 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.28 | Chg30d=-16.67% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.02 | Chg30d=-10.13% | Revisions=+0% | GrowthEPS=-8.1% | GrowthRev=-5.1%
EPS next Year (2027-12-31): EPS=1.43 | Chg30d=+0.71% | Revisions=+25% | GrowthEPS=+39.7% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +29% (up=3, down=1)